Switch View
© PR Newswire
29.08.2025
ISIN: BE0003739530
UCB SA
UCB
LISTED
EURONEXT
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
News Preview
26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsiesData include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning in children and adults with Dravet syndrome or Lennox-Gastaut syndr...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Interim Report - January-June 2025
News Preview
STOCKHOLM – 29 August 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-June 2025. The full report is available on the Company's website....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM
News Preview
OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
29.08.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
NEOG Investors Have Opportunity to Lead Neogen Corporation Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025 (the "Class Period"), of the important September 16, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.08.2025
ISIN: CH0027148649
Santhera Pharmaceuticals Holding AG
SANN
LISTED
SIX
Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India
News Preview
Pratteln, Switzerland, 29 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Ikris Pharma Network (Ikris) to manage the distribution of AGAMREE® (vamorolone) in India, for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older....
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: KR7214450009
Pharmaresearch
214450
LISTED
KOE
PharmaResearch Establishes European Distribution Partnership for 'Rejuran'
News Preview
Secures Strategic Distribution Network Across 22 European Countries, Including Key Markets Such as the UK, Germany, and France
SEONGNAM, South Korea, Aug. 29, 2025 /PRNewswire/ -- PharmaResearch (CEO: Jihoon Sohn), a leading regenerative medicine company, announced today the signing of a strategic partnership agreement with VIVACY, a France-based...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: KR7214450009
Pharmaresearch
214450
LISTED
KOE
PharmaResearch Establishes European Distribution Partnership for 'Rejuran'
News Preview
Secures Strategic Distribution Network Across 22 European Countries, Including Key Markets Such as the UK, Germany, and France
SEONGNAM, South Korea, Aug. 28, 2025 /PRNewswire/ -- PharmaResearch (CEO: Jihoon Sohn), a leading regenerative medicine company, announced today the signing of a strategic partnership agreement with VIVACY, a France-based...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: KYG0330A1013
Alphamab Oncology
9966
LISTED
HKSE
Alphamab Oncology Reports 2025 Interim Results and Business Highlights
News Preview
SUZHOU, China, Aug. 29, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported interim financial results for the six months ended June 30, 2025 and highlighted recent business progress.
Financial Summary
For the six months ended June 30, 2025, we recorded total revenue of RMB 319.44 million, an increase of 84.05% compared with the...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Class Action Reminder: Investors with Large Losses Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Replimune Group, Inc. Class Action Lawsuit
News Preview
SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. (NASDAQ: REPL) securities between November 22, 2024 and July 21, 2025. Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development an...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.08.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender
News Preview
LONDON, UK / ACCESS Newswire / August 29, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), is pleased to announce that following the conclusion of the formal tender process for the role of statutory auditor, it intends to re-appoint PKF Littlejohn LLP as external auditor for the financial year ending December 2025 onwards. This will coincide with...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: KYG3224E1061
Everest Medicines Limited
1952
LISTED
HKSE
Everest Medicines Announces Interim Results for First Half of 2025
News Preview
SHANGHAI, Aug. 29, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2025 along with a corporate update.
"In the first half o...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
ISIN: KYG3224E1061
Everest Medicines Limited
1952
LISTED
HKSE
Everest Medicines Announces Interim Results for First Half of 2025
News Preview
SHANGHAI, Aug. 28, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2025 along with a corporate update.
"In the first half o...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
29.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Berger Montague PC Investigating Claims on Behalf of LifeMD, Inc. (NASDAQ: LFMD) Investors After Class Action Filing
News Preview
PHILADELPHIA, Aug. 28, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period")....
Themefolio
Profiler
Peergroup
© Newsfile
29.08.2025
ISIN: CA74141E1043
PreveCeutical Medical Inc.
PREV
LISTED
CSE
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that, further to its News Release of June 25, 2025, July 8, 2025 and August 5, 2025, it has rescheduled its annual general and special meeting (the "Meeting") from Septem...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US2697961082
Eagle Pharmaceuticals Inc
EGRX
LISTED
NASDAQ
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
News Preview
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has agreed to appoint Abhinav “Abi” Jain as an independent member of its Board of Directors, subject to customary onboarding procedures. Mr. Jain will be a Class III director with an initial term e...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Announces Participation at September 2025 Investor Conferences
News Preview
WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in September 2025:
The Cantor Global Healt...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: CA13509T1057
MTL Cannabis Corp.
MTLC
LISTED
CSE
MTL Cannabis Corp. Reports First Quarter Results with $25.9 Million of Revenue and Announces Transformational Capital Projects
News Preview
Quality Products and Services Drive Continued Positive Operating Income, EBITDA, and Strong Margins
PICKERING, ON, Aug. 28, 2025 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) ("MTL" or the "Company") is pleased to report it has filed the financial statements as at and for the three-month period ending June 30, 2025, and 2024. Complete details may be fo...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics to Participate at Upcoming Investor Conferences
News Preview
SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate at multiple upcoming investor conferences. ...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics to Present at Upcoming Investor Conferences in September 2025
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that Inter...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will participate in a fireside chat hosted by J.P. Morgan on Friday, September 5th, at 1:00 p.m. (ET).
The live webcast of the fireside chat can be accessed via the Investors section of o...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US91324P1021
UnitedHealth Group Inc
UNH
LISTED
NYSE
AM Best Downgrades Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries; Revises Outlooks to Stable
News Preview
AM Best has downgraded the Long-Term Issuer Credit Ratings (Long-Term ICR) to “a-” (Excellent) from “a” (Excellent) and the Long and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. Concurrently AM Best has downgraded the Financial Strength Rating (F...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: CA75103L1013
Rakovina Therapeutics Inc.
RKV
LISTED
TSX
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
News Preview
All dollar amounts reflected in Canadian dollars unless otherwise stated All dollar amounts reflected in Canadian dollars unless otherwise stated...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US83444M1018
Solventum Corporation
SOLV
LISTED
NYSE
Solventum to Participate in Upcoming Investor Conferences
News Preview
ST. PAUL, Minn., Aug. 28, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in fireside chats at the following investor conferences:
2025 Wells Fargo Healthcare Conference in Boston, Mass....
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: IE00B91XRN20
Prothena Corporation PLC
PRTA
LISTED
NASDAQ
Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference
News Preview
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on Thursday, Septem...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health to Host Investor Day on September 24, 2025
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be hosting an Investor Day on September 24, 2025, in New York City, NY starting at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time. The event will feature presentations by several members of the company's leadership team.
Interested parties...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US21217B1008
Contineum Therapeutics, Inc.
CTNM
LISTED
NASDAQ
Contineum Therapeutics to Present at September Investor Conferences
News Preview
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that management is scheduled to present at the following investor conferences in September.
C...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Aug. 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US49372L2097
Kezar Life Sciences Inc
KZR
LISTED
NASDAQ
Kezar Life Sciences to Participate in Two Upcoming Investor Conferences
News Preview
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Chris Kirk, Chief Executive Officer and Co-founder, will participate in two upcoming investor conferences taking place in September:
Event: 2025 Wells...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology to Speak at Upcoming Financial Conferences
News Preview
Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation (NEOG) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
Shareholders with losses of $100,000 or more are encouraged to contact the firm.
LOS ANGELES, Aug. 28, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG)....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US74276R1023
Privia Health Group Inc
PRVA
LISTED
NASDAQ
Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase
News Preview
Privia Health ACOs Delivered $233+M (+32% Y-Y) in Savings in the 2024 MSSP Performance Year; Increases Adjusted EBITDA Guidance for Full-Year 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva gibt Zusammenarbeit mit Global Biotech bekannt, um Innovationen im Bereich klinischer Studien weiter voranzutreiben
News Preview
BARCELONA, Spanien, 28. August 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute eine Zusammenarbeit mit Amgen bekannt, um Innovationen im Bereich klinischer Studien voranzutreiben. Als weltweit führendes Biotechnologieunternehmen wird Amgen die Veeva Clinical Platform einsetzen, um Effizienzsteigerungen im gesamten klinischen Studienproz...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US58510H1032
MEDIROM Healthcare Technologies Inc.
MRM
LISTED
NASDAQ
Medirom’s “REMONY” Certified by MLIT as a Fatigue-Driving Prevention Device
News Preview
TOKYO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”, “we” or “us”) announces that its “REMONY for Driver” remote health management system, developed by its subsidiary MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), has been selected by Japan’s Ministry of Land, Infrastructure, Transport and Tourism (“M...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US5255582018
LeMaitre Vascular Inc
LMAT
LISTED
NASDAQ
LeMaitre to Participate at Upcoming Investor Conferences in September
News Preview
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US3795772082
Globus Medical Inc
GMED
LISTED
NYSE
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.
News Preview
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life Spine, Inc....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US98943L1070
Zentalis Pharmaceuticals Inc
ZNTL
LISTED
NASDAQ
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
News Preview
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that members of the management team will participate in the followi...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US86889P2083
Surrozen, Inc.
SRZN
LISTED
NASDAQ
Surrozen to Present at Upcoming Healthcare Investor Conference
News Preview
Surrozen management will present at the Cantor Global Healthcare Conference 2025 on Thursday, September 4, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US2825591033
89Bio, Inc.
ETNB
LISTED
NASDAQ
89bio to Participate in Upcoming Investor Conferences
News Preview
SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s management will participate in the following investor conferenc...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US14147L1089
Cardiff Oncology Inc
CRDF
LISTED
NASDAQ
Cardiff Oncology to Participate in Three Upcoming Investor Conferences
News Preview
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in the three upcoming investor conferences in September 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US75943R1023
Relay Therapeutics Inc
RLAY
LISTED
NASDAQ
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
News Preview
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in September:...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Securities Fraud Investigation Into LifeMD, Inc. (LFMD) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON LIFEMD, INC. (...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Deadline Alert: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Per...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Medical renforce sa présence en Allemagne en introduisant de nouvelles variétés de cannabis thérapeutique Good Supply
News Preview
Tilray confirme son engagement constant envers le système de santé allemand et élargit l’accès des patients et des pharmacies au plus grand marché européen du cannabis thérapeutique Tilray confirme son engagement constant envers le système de santé allemand et élargit l’accès des patients et des pharmacies au plus grand marché européen du cannabis...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: SE0007692850
Camurus AB
CAMX
LISTED
STO
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
News Preview
LUND, Sweden, Aug. 28, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Oczyesa®, octreotide subcutaneous depot, marketing authorization for the maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment wi...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
News Preview
USA News Group News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Aug. 28, 2025 /PRNewswire/ -- Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with oncology ventures securing hundreds of millions in funding so far in 2025. The Senate...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Faruqi & Faruqi Reminds LifeMD Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 27, 2025 - LFMD
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Fa...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US00847G8042
Agenus Inc
AGEN
LISTED
NASDAQ
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
News Preview
USA News Group News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Aug. 28, 2025 /CNW/ -- Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with oncology ventures securing hundreds of millions in funding so far in 2025. The Senate's rece...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
News Preview
USA News Group News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Aug. 28, 2025 /PRNewswire/ -- Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with oncology ventures securing hundreds of millions in funding so far in 2025. The Senate...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US8740602052
Takeda Pharmaceutical Company
TAK
LISTED
NYSE
Takeda's FRUZAQLA™ (fruquintinib) publicly reimbursed in Quebec for the treatment of metastatic colorectal cancer (mCRC)
News Preview
TORONTO, Aug. 28, 2025 /CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that FRUZAQLATM (fruquintinib capsules) will now be reimbursed by Régie de l'assurance maladie (RAMQ) for people in Quebec, under certain criteria, as a treatment for adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with, or...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US62856X2018
TNF Pharmaceuticals, Inc.
TNFA
LISTED
NASDAQ
TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance
News Preview
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that its board of directors has authorized a reverse stock split of the Company’s common stock at a ratio of 1 post-split share for every 1...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: SE0009807266
Integrum AB (B)
INTEG B
LISTED
STO
Integrum AB: Invitation to the First Quarter 2025/26 Results Presentation
News Preview
MÖLNDAL, Sweden, Aug. 28, 2025 /PRNewswire/ -- Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its first quarter 2025/26 results on September 1, 2025 at 10:00 CET.
Integrum's CEO Martin Hillsten will present the report together with CFO Jörgen Svanström in a webcast. The presentation will be held i...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma to participate in upcoming investor conferences in September 2025
News Preview
Press release – No. 12 / 2025...
Themefolio
Profiler
Peergroup
© Newsfile
28.08.2025
ISIN: CA65347A1021
Nextleaf Solutions Ltd.
OILS
LISTED
CSE
Nextleaf Reports Third Quarter FY25 Results Including Fourth Consecutive Profitable Quarter
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science company and licensed cannabis processor, is pleased to announce its financial results for the third quarter of fiscal year 2025, ended June 30, 202...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
Masimo to Present in the Wells Fargo Healthcare Conference
News Preview
Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.
About Mas...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LIFEMD, INC. (LFMD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ANRO
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO).
Shareholders who purchased shares of ANRO during the class period listed are encouraged...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
The Gross Law Firm Notifies Centene Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - CNC
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Centene Corporation (NYSE: CNC).
Shareholders who purchased shares of CNC during the class period listed are encouraged to co...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action - ALT
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Investors who lost money on Unicycive Therapeutics, Inc.(UNCY) should contact The Gross Law Firm about pending Class Action - UNCY
News Preview
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY).
Shareholders who purchased shares of UNCY during the class period listed are enc...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
